Concepedia
Statistics
Publications
13
Citations
899
H-Index
Active since
1997
Affiliations
Institut Claudius Regaud(Current)
Inserm
Université Toulouse III - Paul Sabatier
University of Pennsylvania
Elizabeth Cohen–Jonathan is an author at Institut Claudius Regaud specializing in medicine, cell biology, and radiation oncology.
Top concepts
MedicineCell BiologyRadiation OncologyTumor BiologyHealthRadiotherapyCell SignalingCell ProliferationRadiation BiologySignal Transduction
Publications per year
1997–2013
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost
S. Ken, L. Vieillevigne, X. Franceries et al. · Radiation Oncology · 2013 · 229 citations · Full text
Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation
Caroline Delmas, Christophe Héliez, Elizabeth Cohen–Jonathan et al. · International Journal of Cancer · 2002 · 88 citations · Full text
High-grade Gliomas, Radiation Biology, Glioma +16
Farnesyltransferase Inhibitors Potentiate the Antitumor Effect of Radiation on a Human Tumor Xenograft Expressing Activated HRAS<sup>1</sup>
Elizabeth Cohen–Jonathan, Ruth J. Muschel, W. Gillies McKenna et al. · Radiation Research · 2000 · 74 citations
The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
Caroline Delmas, D End, Philippe Rochaix et al. · PubMed · 2003 · 70 citations
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
Elizabeth Cohen–Jonathan, Sydney M. Evans, Cameron J. Koch et al. · PubMed · 2001 · 70 citations
Tumor Xenografts, Cancer Biology, Redox Biology +19
1–5 of 13